HK2 and neoplasm: Moreover, other metabolically active tissues, including skeletal muscle, cardiac, and adipose tissues, also express HK2 [62], indicating that the anti-tumor effects of HK2 inhibition may be challenged or limited by non-specificity and systemic toxicity.